Trovagene Offers Cell-Free BRAF Test, Urine-Based Cancer Mutation Monitoring Test
Cell-free DNA assay transferred to CLIA lab for patient testing.
Read MorePosted by Judy O'Rourke | Oct 1, 2013 | Cancer, Molecular Diagnostics |
Cell-free DNA assay transferred to CLIA lab for patient testing.
Read MorePosted by Clinical Lab Products | Sep 30, 2013 | Cancer, Molecular Diagnostics |
Using plasma samples taken during multiple courses of treatment, the researchers derived tumor sequences in patients with advanced cancers. They were then able to identify mutations associated with the emergence of resistance to cancer drugs.
Read MorePosted by Judy O'Rourke | Sep 18, 2013 | Cancer, Molecular Diagnostics, Research |
Data can help scientists and physicians match precision drugs to a cancer’s genetic traits.
Read MorePosted by Judy O'Rourke | Sep 9, 2013 | Molecular Diagnostics, Pancreatic, Research |
Preliminary study needs further confirmation.
Read MorePosted by Judy O'Rourke | Aug 23, 2013 | Molecular Diagnostics |
The company is working with payors nationwide to make this test available to clinicians and cancer patients.
Read More